TheraVet SA (ALVET.PA)
EUR 0.11
(-0.46%)
EUR 0.11
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.21 Million | 373.09 | -1.2 Million | 643.81 Thousand | -425.87 Thousand |
| Net Income | -1.57 Million | -2.77 Million | -1.72 Million | -400.71 Thousand | -98.93 Thousand |
| Depreciation & Amortization | 1.06 Million | 908.65 Thousand | 558.29 Thousand | 46.39 Thousand | 6484.00 |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -679.14 Thousand | -813.57 Thousand | -339.32 Thousand | 970.61 Thousand | -330.38 Thousand |
| Other non-cash items | 2.09 Million | 2.68 Million | 300.7 Thousand | 27.51 Thousand | -3043.00 |
| Investing Cash Flow | -1 Million | -1.55 Million | -3.09 Million | -1.11 Million | -898.84 Thousand |
| Investments in PPE | -1 Million | -1.54 Million | -3.07 Million | -1.11 Million | - |
| Acquisitions | - | - | - | 1800.00 | - |
| Investment purchases | -7234.00 | -10.06 Thousand | -20.8 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -1 Million | -1.54 Million | -3.08 Million | -1.09 Million | -898.84 Thousand |
| Financing Cash Flow | 188.84 Thousand | 139.9 Thousand | 7.76 Million | 2.55 Million | 423.08 Thousand |
| Debt repayment | -103.54 Thousand | -12.51 Thousand | -210.46 Thousand | -349.85 Thousand | -260.02 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | 7.05 Million | 1.87 Million | - |
| Other Financing Activities | 80.64 Thousand | 152.41 Thousand | 925.6 Thousand | 1.03 Million | 163.06 Thousand |
| Accounts receivables | -47.61 Thousand | 77.45 Thousand | -16.47 Thousand | 141.32 Thousand | -305.93 Thousand |
| Accounts payables | -4542.00 | -404 Thousand | 255.06 Thousand | 208.6 Thousand | - |
| Inventory | -32.32 Thousand | 106.31 Thousand | -197.33 Thousand | - | - |
| Other working capital | -594.65 Thousand | -593.33 Thousand | -380.58 Thousand | 620.68 Thousand | -24.44 Thousand |
| Cash at beginning of period | 3.18 Million | 5.36 Million | 2.16 Million | 81.42 Thousand | - |
| Cash at end of period | 1.14 Million | 3.18 Million | 5.63 Million | 2.16 Million | 81.42 Thousand |
| Capital Expenditure | -1 Million | -1.54 Million | -3.07 Million | -1.11 Million | - |
| Effect of forex changes on cash | - | -761.56 Thousand | 1.00 | 1.00 | 983.05 Thousand |
| Net cash flow / Change in cash | -2.03 Million | -2.17 Million | 3.46 Million | 2.08 Million | 81.42 Thousand |
| Free Cash Flow | -2.22 Million | -1.54 Million | -4.28 Million | -469.07 Thousand | -425.87 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -424.35 Thousand | -424.35 Thousand | -332.77 Thousand | -1.57 Million | -332.77 Thousand | -905.15 Thousand |
| Depreciation & Amortization | 189.58 Thousand | 189.58 Thousand | -236.09 Thousand | 1.06 Million | -236.09 Thousand | 686.72 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 159.61 Thousand | 159.61 Thousand | -62.17 Thousand | -679.14 Thousand | -62.17 Thousand | -580.05 Thousand |
| Other non-cash items | 39.68 Thousand | 39.68 Thousand | 414.73 Thousand | 2.09 Million | 414.73 Thousand | 1.4 Million |
| Investing Cash Flow | -211.38 Thousand | -211.38 Thousand | -218.94 Thousand | -1 Million | -218.94 Thousand | -571.4 Thousand |
| Investments in PPE | 82.92 Thousand | - | -432.5 Thousand | -1 Million | - | -569.55 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -5662.00 | - | -5381.00 | -7234.00 | - | -1853.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -211.38 Thousand | -211.38 Thousand | -218.94 Thousand | -1 Million | -218.94 Thousand | -285.7 Thousand |
| Financing Cash Flow | 30.09 Thousand | 30.09 Thousand | 132.01 Thousand | 188.84 Thousand | 132.01 Thousand | -62.2 Thousand |
| Debt repayment | -5949.00 | - | -151.04 Thousand | -103.54 Thousand | - | -47.5 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 30.09 Thousand | 30.09 Thousand | 132.01 Thousand | 80.64 Thousand | 132.01 Thousand | -14.7 Thousand |
| Accounts receivables | 2051.00 | 2051.00 | -37.87 Thousand | -47.61 Thousand | -37.87 Thousand | 28.12 Thousand |
| Accounts payables | 67.38 Thousand | - | 25.25 Thousand | -4542.00 | - | -29.79 Thousand |
| Inventory | -3768.00 | -3768.00 | 49.00 | -32.32 Thousand | 49.00 | -32.42 Thousand |
| Other working capital | 161.33 Thousand | 161.33 Thousand | -24.34 Thousand | -594.65 Thousand | -24.34 Thousand | -545.96 Thousand |
| Cash at beginning of period | 1.14 Million | - | 553.56 Thousand | 3.18 Million | 1.00 | 3.18 Million |
| Cash at end of period | 713.56 Thousand | -216.76 Thousand | 1.14 Million | 1.14 Million | -303.23 Thousand | 553.56 Thousand |
| Capital Expenditure | 82.92 Thousand | - | -432.5 Thousand | -1 Million | - | -569.55 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -1.2 Million |
| Net cash flow / Change in cash | -433.52 Thousand | -216.76 Thousand | 593.52 Thousand | -2.03 Million | -303.24 Thousand | -2.63 Million |
| Free Cash Flow | 47.45 Thousand | -35.46 Thousand | -648.81 Thousand | -2.22 Million | -216.31 Thousand | -1.36 Million |
PCIB
APLM
IDWM
CIE
603393
MEGACPO